Richardson develops intensifier replacements
Richardson Electronics Medical Systems, of LaFox, IL, has introduced two new large-field image intensifier replacements—one designed for Philips’ 36 to 38-cm intensifiers and one for Siemens’ 40-cm intensifier.Over the past 15 years, wear
Richardson Electronics Medical Systems, of LaFox, IL, has introduced two new large-field image intensifier replacementsone designed for Philips 36 to 38-cm intensifiers and one for Siemens 40-cm intensifier.
Over the past 15 years, wear and tear on many large field-of-view image intensifiers has reached the point where there is significant image quality degradation and increased x-ray dose.
Both replacements are based on the Thomson TH9447HX image tube.
The Philips replacement utilizes the original housing, reloaded with the Thomson 16-inch image tube. It can be configured for either RF or angiographic installations, and includes a new power supply and optics.
The Siemens replacement utilizes the same 16-inch tube with Thomson housing, a new power supply, and the original Siemens distributor.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
